Healthcare reform and a desire for universal healthcare are key components of the 13th Five-Year Plan and require commercial industry investment. China acknowledged these goals are dependent on efficient evaluation and approval procedures for medical devices and pharmaceuticals, improved research and development (R&D) of new medicines, and a successful, advanced online system for healthcare management and...
China Market Intelligence
Department of Commerce Requests Comment on Securing ICT Supply Chain Executive Order November 27th, 2019
The Business Reality of China’s Evolving IP Landscape November 26th, 2019
Hill Watch: Unpacking China-Related Proposals November 26th, 2019
New USCC Report Takes Tougher Stance on China, Legislation Could Follow November 26th, 2019
China Releases Blueprint for IP Reforms November 25th, 2019